Groundbreaking research exposes how diabetes damages kidneys, offering hope through early detection and innovative prevention ...

Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Kidney function declined among yo-yo dieters, and they also were more likely to have increased levels of the protein albumin ...

南京鼓楼医院东南大学医学院肾脏病研究所的研究人员 Xue-qi Li 等人在《Acta Pharmacologica Sinica》期刊上发表了题为 “Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic ...

Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Novo Nordisk’s cannabinoid CB1 receptor blocker has run into another problem. | Novo Nordisk’s cannabinoid CB1 receptor blocker has run into another problem. Months after sharing obesity data that ...

AI has demonstrated considerable potential in diabetic foot (DF) management. AI-powered thermal imaging and predictive ...